
|Articles|October 19, 2007
Groups tell Congress to back off fight over ESA dosing decisions
Groups say cancer drug dosing best measured by CMS, Medicaid.
Advertisement
A handful of consumer and health groups have fired the latest salvo in the ongoing battle over Medicare reimbursements for anemia drugs. In a letter sent Wednesday to Congress, the groups-including Consumers Union, U.S. PIRG, the National Research Center for Women & Families, the National Women's Health Network, and the Center for Medical Consumers-urged lawmakers to back off the fight over a CMS
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Meeting at the Crossroads: The Role and Impact of PBMs and BOPs on Pharmacists
2
Pharmacies Adapting to IRA-Negotiated Drug Prices Despite Looming Financial Concerns
3
Pharma, OTC Supplement Are Markets Expected to Grow Billions Come 2032
4
Q&A: New Medicare Drug Prices Proving Detrimental to Pharmacy Cashflow
5









































































































































































































